ZoomMed inc.

ZoomMed inc.

December 30, 2005 23:59 ET

ZoomMed announces the closing of an offering

MONTREAL, Dec. 30 - ZoomMed inc. ("ZoomMed") (TSX Venture
Exchange: ZMD) announces that, on December 30, 2005, pursuant to an amended
prospectus dated December 20, 2005, it completed a first closing resulting in
the issuance of 1,729,500 common shares of the share capital of ZoomMed, at a
price of $0.20 per share. The gross proceeds resulting from the issuance of
these shares is $345,900.

In connection with this offering of shares, ZoomMed has paid to Versant
Partners Inc. ("Versant"), the agent, a cash commission, and has issued to
Versant, as remuneration, warrants entitling it to purchase 86,475 common
shares of ZoomMed, at a price of $0.20 per share, for a period of 18 months.

ZoomMed is presently developing a new electronic tool "ZRx Prescriber",
intended to change the way drugs are prescribed and dispensed throughout
Canada. This handheld prescribing system device, equipped with tools such as a
therapeutic advisor as well as a medication interaction manager, will enable
doctors to fill prescriptions and to electronically transmit them in a fast
and secure mode. This user friendly Web product, designed for doctors, will
use the latest "Pocket PC" technologies.

The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.

Contact Information

  • Yves Marmet
    President and Chief Executive
    (450) 678-5457